reuters.com

P&G to Buy Supplements Maker Thorne for $3.8 Billion in Wellness Push

Procter & Gamble logoProcter & Gamble
Sig3.20Sen+3.70Env0.00Soc+0.90Gov+0.30

P&G will buy supplements maker Thorne for $3.8 billion, accelerating its move into health and wellness as preventive care trends and weight-loss drug popularity lift demand for vitamins and supplements. The deal places P&G alongside rivals competing in the crowded VMS sector, including brands like New Chapter, Metamucil and Align Probiotic. Analysts view premium supplements as a route to younger consumers, and the transaction is expected to deliver over $3 billion in returns for L Catterton.

Coverage (2)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro